Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 318

1.

The FcgammaRIIa-polymorphic site as a potential target for acute graft-versus-host disease in allogeneic stem cell transplantation.

van der Straaten HM, Fijnheer R, Nieuwenhuis HK, van de Winkel JG, Verdonck LF.

Biol Blood Marrow Transplant. 2005 Mar;11(3):206-12.

3.

HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism.

Kawase T, Matsuo K, Kashiwase K, Inoko H, Saji H, Ogawa S, Kato S, Sasazuki T, Kodera Y, Morishima Y; Japan Marrow Donor Program..

Blood. 2009 Mar 19;113(12):2851-8. doi: 10.1182/blood-2008-08-171934.

4.

Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation.

Gallardo D, Aróstegui JI, Balas A, Torres A, Caballero D, Carreras E, Brunet S, Jiménez A, Mataix R, Serrano D, Vallejo C, Sanz G, Solano C, Rodríguez-Luaces M, Marín J, Baro J, Sanz C, Román J, González M, Martorell J, Sierra J, Martín C, de la Cámara R, Grañena A; GvHD Subcommittee of the Grupo Español de Trasplante Hemapoyético (GETH)..

Br J Haematol. 2001 Sep;114(4):931-6.

PMID:
11564088
5.

Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation.

van der Straaten HM, Fijnheer R, Dekker AW, Nieuwenhuis HK, Verdonck LF.

Br J Haematol. 2001 Jul;114(1):31-5.

PMID:
11472341
7.

Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.

Kataoka I, Kami M, Takahashi S, Kodera Y, Miyawaki S, Hirabayashi N, Okamoto S, Matsumoto N, Miyazaki Y, Morishita Y, Asai O, Maruta A, Yoshida T, Imamura M, Hamajima N, Matsuo K, Harada M, Mineishi S; Japan Society for Hematopoietic Cell Transplantation Working Party..

Bone Marrow Transplant. 2004 Oct;34(8):711-9.

PMID:
15361916
8.

Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.

Laurin D, Hannani D, Pernollet M, Moine A, Plumas J, Bensa JC, Cahn JY, Garban F.

Transfusion. 2010 Feb;50(2):418-28. doi: 10.1111/j.1537-2995.2009.02440.x.

PMID:
19843288
9.
10.

Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Socié G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E, Charron D.

Transplantation. 2001 Aug 27;72(4):699-706.

PMID:
11544434
11.

Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.

Talmadge JE.

Int Immunopharmacol. 2003 Aug;3(8):1121-43. Review.

PMID:
12860168
12.

[Role of polymorphic adhesion molecules in the development of graft-versus-leukemia effect after HLA-matched allogeneic stem cell transplantation].

Shiobara S, Sato H, Furukawa T, Tsukada J, Yasue S, Takeda H, Togawa A, Taira M, Sakai Y, Aizawa Y, Nakao S.

Rinsho Ketsueki. 2004 Jul;45(7):518-23. Japanese.

PMID:
15359910
13.

The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors.

Remberger M, Mattsson J, Hentschke P, Aschan J, Barkholt L, Svennilson J, Ljungman P, Ringdén O.

Bone Marrow Transplant. 2002 Dec;30(11):761-8.

14.

The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.

Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K, Ishikawa Y, Kato S, Sao H, Sakamaki H, Kawa K, Hamajima N, Asano S, Kodera Y.

Blood. 2002 Jun 1;99(11):4200-6.

15.
16.

The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease.

Kim SY, Lee DG, Kim MS, Kim HJ, Lee S, Min CK.

Am J Hematol. 2008 Oct;83(10):784-8. doi: 10.1002/ajh.21227.

17.

The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.

Sánchez-García J, Serrano J, Gómez P, Martínez F, Martín C, Román-Gómez J, Rodríguez A, Herrera C, García JM, Alvarez MA, Torres A.

Haematologica. 2006 Mar;91(3):340-7.

18.

Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.

Spierings E, Kim YH, Hendriks M, Borst E, Sergeant R, Canossi A, Oudshoorn M, Loiseau P, Dolstra H, Markiewicz M, Leffell MS, Pereira N, Kircher B, Turpeinen H, Eliaou JF, Gervais T, Laurin D, Enczmann J, Martinetti M, Thomson J, Oguz F, Santarone S, Partanen J, Siekiera U, Alessandrino EP, Kalayoglu S, Brand R, Goulmy E.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1244-53. doi: 10.1016/j.bbmt.2013.06.001.

19.

Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.

Liu QF, Li YQ, Yang D, Zhang Y, Yang LJ, Chen SH, Sun J, Liu XL, Zhou SY.

Chin Med J (Engl). 2004 Mar;117(3):413-8.

PMID:
15043783
20.

Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect.

Huang XJ, Wang Y, Liu DH, Xu LP, Liu KY, Chen H, Chen YH, Han W, Shi HX.

Bone Marrow Transplant. 2009 Sep;44(5):309-16. doi: 10.1038/bmt.2009.26.

PMID:
19234512
Items per page

Supplemental Content

Support Center